Sign In
Buy ANIK
$14.41
+0.0300 (+0.209%)
At Close: Jun 03, 2026
/PRNewswire/ -- The "Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis (Single Injection, Three...
Dublin, Feb. 26, 2020 -- The "Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis (Single Injection, Three.
Anika Therapeutics (NASDAQ:ANIK) Rating Lowered to Sell at Zacks Investment Research
08:54am, Wednesday, 26'th Feb 2020
Anika Therapeutics (NASDAQ:ANIK) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Monday, Zacks.com reports. According to Zack
Anika Therapeutics (NASDAQ:ANIK) Upgraded by BidaskClub to "Sell"
08:16am, Wednesday, 26'th Feb 2020
Anika Therapeutics (NASDAQ:ANIK) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a note issued to investors on Wednesday, BidAskClub
Analysts Offer Insights on Healthcare Companies: Endologix (ELGX) and Merit Medical Systems (MMSI)
02:33pm, Tuesday, 25'th Feb 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Endologix (ELGX) and Merit Medical Systems (MMSI). Endologix (ELGX) BTIG
Analysts Offer Insights on Healthcare Companies: Endologix (NASDAQ: ELGX) and Merit Medical Systems (NASDAQ: MMSI)
02:33pm, Tuesday, 25'th Feb 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Endologix (
ELGX
–
Research Report
) and Merit Medical Systems (
MMSI
–
Research Report
).
Endologix (ELGX)
BTIG a
Anika Therapeutics (NASDAQ:ANIK) Downgraded by ValuEngine to "Strong Sell"
07:24am, Tuesday, 25'th Feb 2020
Anika Therapeutics (NASDAQ:ANIK) was downgraded by stock analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Tuesday,
A Look At The Fair Value Of Anika Therapeutics, Inc. (NASDAQ:ANIK)
10:49am, Monday, 24'th Feb 2020
In this article we are going to estimate the intrinsic value of Anika Therapeutics, Inc. (NASDAQ:ANIK) by estimating...
First Analysis Analysts Reduce Earnings Estimates for Anika Therapeutics Inc (NASDAQ:ANIK)
07:36am, Monday, 24'th Feb 2020
Anika Therapeutics Inc (NASDAQ:ANIK) – Equities research analysts at First Analysis dropped their Q2 2020 EPS estimates for Anika Therapeutics in a research report issued on Friday, February 21st. F
Anika Therapeutics Beats Revenue and Earnings Estimates
04:52pm, Friday, 21'st Feb 2020
A recent acquisition and a new product launch held back earnings, but should be beneficial over the long term.
Barrington Research Reiterates Buy Rating for Anika Therapeutics (NASDAQ:ANIK)
04:50pm, Friday, 21'st Feb 2020
Anika Therapeutics (NASDAQ:ANIK)‘s stock had its “buy” rating reaffirmed by investment analysts at Barrington Research in a research report issued to clients and investors on Friday, AnalystRati
Barrington Maintains a Buy Rating on Anika Therapeutics (ANIK)
03:08pm, Friday, 21'st Feb 2020
In a report released today, Michael Petusky from Barrington maintained a Buy rating on Anika Therapeutics (ANIK), with a price target of $60.00. The
Barrington Maintains a Buy Rating on Anika Therapeutics (ANIK)
03:08pm, Friday, 21'st Feb 2020
In a report released today,
Michael Petusky
from Barrington maintained a
Buy
rating on Anika Therapeutics (
ANIK
–
Research Report
), with a price target of
$60.00
. The company’s shares closed la
The "Viscosupplementation: Global Market Overview" report has been added to ResearchAndMarkets.com's offering.
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
12:46pm, Friday, 21'st Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose B
